Year |
Citation |
Score |
2023 |
Park WY, Gray JM, Holewinski RJ, Andresson T, So JY, Carmona-Rivera C, Hollander MC, Yang HH, Lee M, Kaplan MJ, Cappell SD, Yang L. Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathway. Nature Cancer. 4: 419-435. PMID 36973439 DOI: 10.1038/s43018-023-00524-z |
0.357 |
|
2022 |
Gibbs C, So JY, Ahad A, Michalowski AM, Son DS, Li Y. CXCL14 Attenuates Triple-Negative Breast Cancer Progression by Regulating Immune Profiles of the Tumor Microenvironment in a T Cell-Dependent Manner. International Journal of Molecular Sciences. 23. PMID 36012586 DOI: 10.3390/ijms23169314 |
0.433 |
|
2022 |
So JY, Yang HH, Park WY, Skrypek N, Ishii H, Chen JM, Lee MP, Yang L. DNA methyltransferase 3B-mediated intra-tumoral heterogeneity and therapeutic targeting in breast cancer recurrence and metastasis. Molecular Cancer Research : McR. PMID 35857355 DOI: 10.1158/1541-7786.MCR-21-0887 |
0.415 |
|
2020 |
Yang L, So JY, Skrypek N, Yang HH, Merchant AS, Nelson GW, Chen WD, Ishii H, Chen JM, Hu G, Achyut BR, Yoon EC, Han L, Huang C, Cam MC, et al. Induction of DNMT3B by PGE2 and IL6 at distant metastatic sites promotes epigenetic modification and breast cancer colonization. Cancer Research. PMID 32265226 DOI: 10.1158/0008-5472.Can-19-3339 |
0.376 |
|
2019 |
Liu F, Zhou J, Kundu-Roy T, Wahler J, So JY, Lin Y, Lou Y, Barnard NJ, Matsuura I, Suh N. Abstract 1073: Role of CD44 in the transition of ductal carcinomain situto invasive breast carcinoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1073 |
0.633 |
|
2016 |
Belorusova AY, Suh N, Lee HJ, So JY, Maehr H, Rochel N. Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D. The Journal of Steroid Biochemistry and Molecular Biology. PMID 27650654 DOI: 10.1016/J.Jsbmb.2016.09.015 |
0.676 |
|
2015 |
Das Gupta S, Sae-Tan S, Wahler J, So JY, Bak MJ, Cheng LC, Lee MJ, Lin Y, Shih WJ, Shull JD, Safe S, Yang CS, Suh N. Dietary γ-Tocopherol Rich Mixture Inhibits Estrogen-Induced Mammary Tumorigenesis by Modulating Estrogen Metabolism, Antioxidant Response and PPARγ. Cancer Prevention Research (Philadelphia, Pa.). PMID 26130252 DOI: 10.1158/1940-6207.Capr-15-0154 |
0.726 |
|
2015 |
So JY, Wahler J, Das Gupta S, Salerno DM, Maehr H, Uskokovic M, Suh N. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 148: 111-21. PMID 25541438 DOI: 10.1016/J.Jsbmb.2014.12.013 |
0.74 |
|
2015 |
So JY, Suh N. Targeting cancer stem cells in solid tumors by vitamin D. The Journal of Steroid Biochemistry and Molecular Biology. 148: 79-85. PMID 25460302 DOI: 10.1016/J.Jsbmb.2014.10.007 |
0.714 |
|
2015 |
Wahler J, So JY, Cheng LC, Maehr H, Uskokovic M, Suh N. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 148: 148-55. PMID 25445919 DOI: 10.1016/J.Jsbmb.2014.10.016 |
0.74 |
|
2015 |
Gupta SD, Sae-tan S, Wahler J, So JY, Cheng LC, Bak MJ, Lee M, Lin Y, Shih WJ, Yang CS, Suh N. Abstract 2797: Dietary administration of a γ-tocopherol rich mixture of tocopherols inhibits estrogen-mediated mammary tumorigenesis Cancer Research. 75: 2797-2797. DOI: 10.1158/1538-7445.Am2015-2797 |
0.656 |
|
2014 |
So JY, Lin JJ, Wahler J, Liby KT, Sporn MB, Suh N. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer. Plos One. 9: e107616. PMID 25229616 DOI: 10.1371/Journal.Pone.0107616 |
0.715 |
|
2014 |
Das Gupta S, So JY, Wall B, Wahler J, Smolarek AK, Sae-Tan S, Soewono KY, Yu H, Lee MJ, Thomas PE, Yang CS, Suh N. Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats. Molecular Carcinogenesis. PMID 24782330 DOI: 10.1002/Mc.22164 |
0.798 |
|
2014 |
Wahler J, So JY, Kim YC, Liu F, Maehr H, Uskokovic M, Suh N. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog. Cancer Prevention Research (Philadelphia, Pa.). 7: 617-26. PMID 24691501 DOI: 10.1158/1940-6207.Capr-13-0362 |
0.725 |
|
2014 |
Gupta SD, So JY, Wahler J, Lee M, Yang CS, Suh N. Abstract 243: Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats Cancer Research. 74: 243-243. DOI: 10.1158/1538-7445.Am2014-243 |
0.673 |
|
2014 |
So JY, Salerno DM, Maehr H, Uskokovic M, Suh N. Abstract 1248: The Gemini vitamin D analogue BXL0124 inhibits Notch signaling via HES1, resulting in the reduction of CD44+/CD24-/low subpopulation and proliferation of MCF10DCIS cells Cancer Research. 74: 1248-1248. DOI: 10.1158/1538-7445.Am2014-1248 |
0.719 |
|
2013 |
So JY, Wahler JE, Yoon T, Smolarek AK, Lin Y, Shih WJ, Maehr H, Uskokovic M, Liby KT, Sporn MB, Suh N. Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression. Cancer Prevention Research (Philadelphia, Pa.). 6: 959-70. PMID 23856074 DOI: 10.1158/1940-6207.Capr-13-0087 |
0.827 |
|
2013 |
So JY, Smolarek AK, Salerno DM, Maehr H, Uskokovic M, Liu F, Suh N. Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to Inhibition of Invasion in Basal-Like Breast Cancer Plos One. 8. PMID 23326564 DOI: 10.1371/Journal.Pone.0054020 |
0.825 |
|
2013 |
Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang CX, Saw CL, Khor TO, Kong AN, Reuhl K, Lee MJ, Yang CS, Suh N. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Molecular Carcinogenesis. 52: 514-25. PMID 22389237 DOI: 10.1002/Mc.21886 |
0.798 |
|
2013 |
Liu F, Roy T, So JY, Smolarek A, Lu Y, Suh N. Abstract 780: Knockdown of p53 increases tumorigenicity of human breast cancer cells. Cancer Research. 73: 780-780. DOI: 10.1158/1538-7445.Am2013-780 |
0.815 |
|
2013 |
Wahler J, So JY, Smolarek A, Maehr H, Uskokovic M, Suh N. Abstract 184: A gemini vVitamin D analog, BXL0124, inhibits mammary tumorigenesis by delaying the transition of ductal carcinoma in situ to iInvasive breast carcinoma. Cancer Research. 73: 184-184. DOI: 10.1158/1538-7445.Am2013-184 |
0.827 |
|
2013 |
So JY, Smolarek AK, Maehr H, Uskokovic M, Liby K, Sporn MB, Suh N. Abstract 180: Inhibition of tumorigenesis by a novel Gemini vitamin D analog BXL0124 and a synthetic triterpenoid CDDO-Im in MMTV-HER2/neu transgenic mice. Cancer Research. 73: 180-180. DOI: 10.1158/1538-7445.Am2013-180 |
0.836 |
|
2012 |
So JY, Lee HJ, Kramata P, Minden A, Suh N. Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression Model. Molecular and Cellular Pharmacology. 4: 31-40. PMID 24558516 DOI: 11.4255/mcpharmacol.12.03 |
0.679 |
|
2012 |
Smolarek AK, So JY, Burgess B, Kong AN, Reuhl K, Lin Y, Shih WJ, Li G, Lee MJ, Chen YK, Yang CS, Suh N. Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer. Cancer Prevention Research (Philadelphia, Pa.). 5: 1310-20. PMID 22964476 DOI: 10.1158/1940-6207.Capr-12-0263 |
0.826 |
|
2012 |
So JY, Smolarek AK, Shah N, Maehr H, Uskokovic M, Liu F, Suh N. Abstract 929: Repression of CD44 is a key molecular action of a novel Gemini vitamin D BXL0124 to inhibit breast cancer cell invasion induced by HGF/Met signaling Cancer Research. 72: 929-929. DOI: 10.1158/1538-7445.Am2012-929 |
0.835 |
|
2011 |
Suh N, Reddy BS, DeCastro A, Paul S, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele V, Rao CV. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Cancer Prevention Research (Philadelphia, Pa.). 4: 1895-902. PMID 21764859 DOI: 10.1158/1940-6207.Capr-11-0222 |
0.795 |
|
2011 |
So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, Uskokovic M, Zheng X, Conney AH, Cai L, Liu F, Suh N. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer. Molecular Pharmacology. 79: 360-7. PMID 21115634 DOI: 10.1124/Mol.110.068403 |
0.818 |
|
2011 |
So JY, Smolarek AK, Maehr H, Uskokovic M, Cai L, Liu F, Suh N. Abstract 839: A novel Gemini vitamin D analog represses a stem cell marker CD44 and its variant CD44v6 and inhibits CD44-Met signaling in breast cancer Cancer Research. 71: 839-839. DOI: 10.1158/1538-7445.Am2011-839 |
0.839 |
|
2011 |
Suh N, Reddy BS, Paul S, DeCastro A, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Janakiram NB, Steele VE, Rao CV. Abstract 833: Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/beta-catenin/cyclin D1 signaling pathway in rats Cancer Research. 71: 833-833. DOI: 10.1158/1538-7445.Am2011-833 |
0.796 |
|
2011 |
Smolarek AK, So JY, Thomas PE, Lee HJ, Paul S, Dombrowski A, Wang C, Kong AT, Reuhl K, Lee M, Yang CS, Suh N. Abstract 1851: Dietary mixed tocopherols inhibit cell proliferation in mammary hyperplasia, suppress the expression of inflammatory markers, and upregulate PPARγ Cancer Research. 71: 1851-1851. DOI: 10.1158/1538-7445.Am2011-1851 |
0.778 |
|
2010 |
Lee HJ, So JY, DeCastro A, Smolarek A, Paul S, Maehr H, Uskokovic M, Suh N. Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling. The Journal of Steroid Biochemistry and Molecular Biology. 121: 408-12. PMID 20304052 DOI: 10.1016/J.Jsbmb.2010.03.053 |
0.801 |
|
2010 |
Paul S, DeCastro AJ, Lee HJ, Smolarek AK, So JY, Simi B, Wang CX, Zhou R, Rimando AM, Suh N. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis. 31: 1272-8. PMID 20061362 DOI: 10.1093/Carcin/Bgq004 |
0.796 |
|
2010 |
So JY, Lee HJ, Smolarek AK, Paul S, Maehr H, Uskokovic M, Cai L, Liu F, Suh N. Abstract 644: A novel Gemini vitamin D analogue represses the expression of a stem cell marker CD44 in breast cancer Cancer Research. 70: 644-644. DOI: 10.1158/1538-7445.Am10-644 |
0.821 |
|
2009 |
Lee HJ, Ju J, Paul S, So JY, DeCastro A, Smolarek A, Lee MJ, Yang CS, Newmark HL, Suh N. Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4242-9. PMID 19509159 DOI: 10.1158/1078-0432.Ccr-08-3028 |
0.76 |
|
Low-probability matches (unlikely to be authored by this person) |
2022 |
So JY, Ohm J, Lipkowitz S, Yang L. Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacology & Therapeutics. 108253. PMID 35872332 DOI: 10.1016/j.pharmthera.2022.108253 |
0.297 |
|
2018 |
Ishii H, Vodnala SK, Achyut BR, So JY, Hollander MC, Greten TF, Lal A, Yang L. miR-130a and miR-145 reprogram Gr-1CD11b myeloid cells and inhibit tumor metastasis through improved host immunity. Nature Communications. 9: 2611. PMID 29973593 DOI: 10.1038/s41467-018-05023-9 |
0.162 |
|
2017 |
Yeon S, So JY, Yun JH, Park S, Shin K, Jin C, Lee YJ. Effect of Phosphate Additive for Thermal Stability in a Vanadium Redox Flow Battery Journal of Electrochemical Energy Conversion and Storage. 14. DOI: 10.1115/1.4038019 |
0.096 |
|
2017 |
Yeon S, Kim D, Lee S, Nam S, Park S, So JY, Shin K, Jin C, Park Y, Kang YC. High microporosity of carbide-derived carbon prepared from a vacuum-treated precursor for energy storage devices Carbon. 118: 327-338. DOI: 10.1016/J.Carbon.2017.03.063 |
0.039 |
|
2013 |
Kim SK, Son JM, So JY, Kim H, Lee K, Oh SS, Ko SB. The Relationship between Waist Circumference and Work-related Injury in Reference to the Fourth Korea National Health and Nutrition Examination Survey. Annals of Occupational and Environmental Medicine. 25: 29. PMID 24472303 DOI: 10.1186/2052-4374-25-29 |
0.023 |
|
Hide low-probability matches. |